Citius Pharmaceuticals, Inc. Deposits Assets
Citius Pharmaceuticals, Inc. (CTXR) had Deposits Assets of $38.06 thousand as of 2024-06-30, per its 10-Q filed 2024-08-12.
Discontinued › Balance Sheet › Assets
us-gaap:DepositsAssets · last filed 2024-08-12
- 2024-06-30: Deposits Assets $38.06K.
- 2024-03-31: Deposits Assets $38.06K.
- 2023-12-31: Deposits Assets $38.06K.
- 2023-09-30: Deposits Assets $38.06K.
| Period end | Deposits Assets |
|---|---|
| 2024-06-30 | $38.06K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $38.06K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $38.06K 10-Q · filed 2024-02-14 |
| 2023-09-30 | $38.06K 10-Q · filed 2024-08-12 |
| 2023-06-30 | $38.06K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $38.06K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $38.06K 10-Q · filed 2023-02-10 |
| 2022-09-30 | $38.06K 10-K · filed 2023-12-29 |
| 2022-06-30 | $38.06K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $38.06K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $38.06K 10-Q · filed 2022-02-10 |
| 2021-09-30 | $38.06K 10-K · filed 2022-12-22 |
| 2021-06-30 | $38.06K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $38.06K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $38.06K 10-Q · filed 2021-02-11 |
| 2020-09-30 | $57.09K 10-K · filed 2021-12-15 |
| 2020-06-30 | $57.09K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $57.09K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $57.09K 10-Q · filed 2020-02-13 |
| 2019-09-30 | $57.09K 10-K · filed 2020-12-16 |
| 2019-03-31 | $2.17K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $2.17K 10-Q · filed 2019-02-14 |
| 2018-09-30 | $2.17K 10-K · filed 2019-12-16 |
| 2018-06-30 | $2.17K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $2.17K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $2.17K 10-Q · filed 2018-02-14 |
| 2017-09-30 | $2.17K 10-K · filed 2018-12-11 |
| 2017-06-30 | $2.17K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $2.17K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $2.17K 10-Q · filed 2017-02-14 |
| 2016-09-30 | $2.17K 10-K · filed 2017-12-13 |
| 2016-06-30 | $2.17K 10-Q · filed 2016-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |